Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | EYA2 | O00167 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrilotriacetic Acid SCHEMBL9624643 | 0.97 | KDM4E (0.50) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL30150827 | 0.97 | KDM4E (0.50) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL9625156 | 0.97 | KDM4E (0.50) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL11309540 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL1284701 | 0.93 | KDM4E (0.59) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL23358712 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL1684921 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL2810628 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL1535541 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 | |
| Nitrilotriacetic Acid SCHEMBL11684108 | 0.93 | KDM4E (0.52) | KDM4EALOX15MAPTSMN1; SMN2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114833491-B | Copper surface selective organic soldering flux and use method thereof | 广东哈福技术股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-115312704-A | Preparation method and application of material containing rich oxygen sites for modifying metal zinc negative electrode | 浙江理工大学 | 2022-11-08 | — | — | CN | claimed |
| CN-114833491-A | Copper surface selective organic solderability preservative and use method thereof | 广东哈福科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-112457895-B | Sulfur precipitator, desulfurization system and application thereof | 中国石油化工集团有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-112457895-A | Sulfur precipitator, desulfurization system and application thereof | 中国石油化工集团有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-111257549-A | Kit and method for detecting unsaturated iron binding force in serum | 深圳迈瑞生物医疗电子股份有限公司 | 2020-06-09 | — | — | CN | claimed |
| CN-110922448-A | Phosphorylated peptide enrichment device and method | 谱度众合(武汉)生命科技有限公司 | 2020-03-27 | — | — | CN | claimed |
| US-4871520-A | Process and composition for H2 S removal | SHELL OIL COMPANY (US) | 1989-10-03 | — | — | US | claimed |
| US-4859436-A | H2 S removal process and composition | SHELL OIL COMPANY (US) | 1989-08-22 | — | — | US | claimed |
| CN-114833491-B | Copper surface selective organic soldering flux and use method thereof | 广东哈福技术股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-114833491-B | Copper surface selective organic soldering flux and use method thereof | 广东哈福技术股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117042811-A | Composition for cancer imaging | 安斯泰来制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20230255982-A1 | METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF | Reata Pharmaceuticals Holdings, LLC (US) | 2023-08-17 | — | — | US | disclosed |
| CN-116286368-A | Desulfurizing bacteria preservative | 江西永丰博源实业有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-4859436-A | H2 S removal process and composition | SHELL OIL COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| US-4664902-A | Recovery of sulfur from a solid sulfur-containing solution of solubilized iron chelate of nitrilotriacetic acid | SHELL OIL COMPANY (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0066309-B1 | SULPHUR RECOVERY PROCESS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-03-27 | — | — | EP | disclosed |
| US-4363215-A | CATALYTIC OXIDATION WITH HYDROGEN PEROXIDE | PACIFIC GAS AND ELECTRIC COMPANY (US) | 1982-12-14 | — | — | US | disclosed |
| EP-0066309-A1 | Sulphur recovery process | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-12-08 | — | — | EP | disclosed |
| US-4348368-A | Method of removing hydrogen sulfide from gases | SHELL OIL COMPANY (US) | 1982-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255982-A1 | METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF | CYP17A1, HSD11B2, HSD11B1 | KDM4E 1007/4885ALOX15 27/4885MAPT 4476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.